MitoQ Ltd   Report issue

For profit Phase 2
Founded: Auckland New Zealand (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2017
NCT03166800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MitoQ